Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has responded to a BSE query dated September 12, 2025 regarding unusual price movement in its stock. The company clarified that there is no undisclosed price-sensitive information under SEBI LODR Regulation 30 that could explain the price/volume behavior. It stated the price movement is purely market-driven and beyond the company's control. The company also affirmed that it has been regularly sharing all required disclosures with the exchanges.
This is a standard no-impact clarification — typically a neutral signal. However, exchanges sometimes seek such clarifications when they suspect possible insider trading or undisclosed developments, so investors may want to watch for any upcoming announcements or fundamentals news to confirm the company's claim of nothing material pending.